These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30369424)

  • 1. Cleaning of inpatient nebulizer devices in cystic fibrosis patients: the urgent need for universal guidelines.
    Bell J; Moore JE; Millar BC
    J Hosp Infect; 2018 Nov; 100(3):e64-e66. PubMed ID: 30369424
    [No Abstract]   [Full Text] [Related]  

  • 2. Nebulizer cleaning and disinfection practices in families with cystic fibrosis: The relationship between attitudes, practice and microbe colonization.
    Murray TS; O'Rourke TK; Feinn R; Drapeau G; Collins MS
    J Cyst Fibros; 2019 Nov; 18(6):823-828. PubMed ID: 31126899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of different steam disinfection protocols for cystic fibrosis nebulizers.
    Hohenwarter K; Prammer W; Aichinger W; Reychler G
    J Cyst Fibros; 2016 Jan; 15(1):78-84. PubMed ID: 26233897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem.
    Riquena B; Monte LFV; Lopes AJ; Silva-Filho LVRFD; Damaceno N; Aquino EDS; Marostica PJC; Ribeiro JD
    J Bras Pneumol; 2019 May; 45(3):e20170351. PubMed ID: 31166553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated hot water and steam disinfection of Pari LC Plus® nebulizers alter nebulizer output.
    Collins MS; O'Brien M; Schramm CM; Murray TS
    J Cyst Fibros; 2019 Mar; 18(2):233-235. PubMed ID: 30224332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does repeated disinfection of the e-Flow rapid nebulizer affect in vitro performance?
    Bakuridze L; Andrieu V; Dupont C; Dubus JC
    J Cyst Fibros; 2007 Jul; 6(4):309-10. PubMed ID: 17276148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulizer decontamination.
    Allan J; Cunniffe JG; Edwards C; Kretzer D; Ledgerton A; Mackintosh C; Murray AE
    J Hosp Infect; 2005 Jan; 59(1):72-4. PubMed ID: 15571859
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers.
    Della Zuana A; Garcia Dde O; Juliani RC; Silva Filho LV
    J Bras Pneumol; 2014; 40(2):119-27. PubMed ID: 24831395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
    Brzezinski LX; Riedi CA; Kussek P; Souza HH; Rosário N
    J Bras Pneumol; 2011; 37(3):341-7. PubMed ID: 21755189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disinfection of devices for nebulization: stakes, difficulties, and improvement proposals].
    Reychler G; Dupont C; Dubus JC; ;
    Rev Mal Respir; 2007 Dec; 24(10):1351-61. PubMed ID: 18216754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulizer use and maintenance by cystic fibrosis patients: a survey study.
    Lester MK; Flume PA; Gray SL; Anderson D; Bowman CM
    Respir Care; 2004 Dec; 49(12):1504-8. PubMed ID: 15571641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Staphylococcus aureus (MSSA and MRSA) to drying: implications for nebulizer hygiene in patients with cystic fibrosis.
    Moore JE; Millar BC
    J Hosp Infect; 2020 Jun; 105(2):366-367. PubMed ID: 32298736
    [No Abstract]   [Full Text] [Related]  

  • 13. Soluble squalamine tablets for the rapid disinfection of home nebulizers of cystic fibrosis patients.
    Djouhri-Bouktab L; Alhanout K; Andrieu V; Stremler N; Dubus JC; Raoult D; Rolain JM; Brunel JM
    J Cyst Fibros; 2012 Dec; 11(6):555-9. PubMed ID: 22727722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis.
    Denton M; Rajgopal A; Mooney L; Qureshi A; Kerr KG; Keer V; Pollard K; Peckham DG; Conway SP
    J Hosp Infect; 2003 Nov; 55(3):180-3. PubMed ID: 14572484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalation equipment hygiene: a belgian national survey.
    Reychler G; Bosschaerts M; Chevaillier J; Gaspar V; Lessire F; Opdekamp C; Van Ginderdeuren F; Vanlaethem S; Vreys M; Vrijsen B;
    J Aerosol Med Pulm Drug Deliv; 2009 Sep; 22(3):239-43. PubMed ID: 19466909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleaning and infection control of airway clearance devices used by CF patients.
    Manor E; Gur M; Geffen Y; Bentur L
    Chron Respir Dis; 2017 Nov; 14(4):370-376. PubMed ID: 28513198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-infection and the use and decontamination of placebo inhalers.
    Clancy K
    Br J Nurs; 2003 Jul 10-23; 12(13):778-83. PubMed ID: 12920455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hypochlorite-based disinfection on bacterial contamination of cystic fibrosis patients' home-nebulisers.
    Reychler G; Leonard A; Van Ossel C; Godding V; Gigi J; Simon A; Lebecque P
    J Hosp Infect; 2009 Aug; 72(4):351-7. PubMed ID: 19596489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
    Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
    Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ozone disinfection of home nebulizers effectively kills common cystic fibrosis bacterial pathogens.
    Towle D; Baker V; Schramm C; O'Brien M; Collins MS; Feinn R; Murray TS
    Pediatr Pulmonol; 2018 May; 53(5):599-604. PubMed ID: 29542874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.